Strikingly, sRANKL positively correlated with markers of organ failure or dysfunction, especially with markers of liver injury (e.g., ALT, prothrombin time) and cholestasis (e.g., yGT, ALP, bilirubin). This evidence concerns the gene F2 and cholestasis.